Reports

To assist health care providers, policy-makers, and consumers in making well-informed decisions about the prescribing and use of blood glucose test strips, our completed research and resulting recommendations are available in a series of Optimal Therapy Reports that provide:

• evidence-based clinical statements and cost-effectiveness statements
• a clear picture of current practice in Canada regarding the use of blood glucose test strips
• an analysis of the quantity of blood glucose test strips prescribed, including market share and cost information
• an outline of gaps between current prescribing and use.

Summary Reports

• Executive Summary (nine-page synopsis of clinical reports)
• Project in Brief (one-page synopsis of clinical reports)

Final reports

• Gap Analysis and Key Messages for the Prescribing and Use of Blood Glucose Test Strips for the Self-Monitoring of Blood Glucose. Optimal Therapy Report - COMPUS 2009;3(7).
• Optimal Therapy Recommendations for the Prescribing and Use of Blood Glucose Test Strips. Optimal Therapy Report – COMPUS 2009;3(6).
• Current Practice Analysis of Health Care Providers and Patients on Self-Monitoring of Blood Glucose. Optimal Therapy Report - COMPUS 2009;3(5).
• Current Utilization of Blood Glucose Test Strips in Canada. Optimal Therapy Report – COMPUS 2009;3(4).
• Cost Effectiveness of Blood Glucose Test Strips in the Management of Adult Patients with Diabetes Mellitus. Optimal Therapy Report – COMPUS 2009;3(3).
• Systematic Review of Use of Blood Glucose Test Strips for the Management of Diabetes Mellitus. Optimal Therapy Report – COMPUS 2009;3(2).
• Use of Blood Glucose Test Strips for the Management of Diabetes Mellitus – Project Protocol. Optimal Therapy Report - COMPUS 2008;3(1).

Related Information

• Background on Self-Monitoring of Blood Glucose (Report and Findings-at-a-Glance)
• Media Contacts and Key Links
• Frequently Asked Questions